NCT05882175View on ClinicalTrials.gov

Prospective Validation of the OHI Index

RecruitingOBSERVATIONAL
Enrollment

300

Participants

Timeline

Start Date

March 3, 2021

Primary Completion Date

March 3, 2030

Study Completion Date

March 3, 2030

Conditions
HLHHemophagocytic LymphohistiocytosesHemophagocytic SyndromeHematologic MalignancyHematologic Neoplasms
Trial Locations (2)

49100

RECRUITING

Rabin Medical Center, Petah Tikva

4428164

RECRUITING

Meir Medical Center, Kfar Saba

Sponsors
All Listed Sponsors
collaborator

Children's Hospital Medical Center, Cincinnati

OTHER

collaborator

Rabin Medical Center

OTHER

collaborator

Sheba Medical Center

OTHER_GOV

collaborator

Schneider Children's Medical Center, Israel

OTHER

lead

Meir Medical Center

OTHER

NCT05882175 - Prospective Validation of the OHI Index | Biotech Hunter | Biotech Hunter